Hojabr Alimi Insider Profile
4 Followers
Hojabr Alimi, CEO, Director at Sonoma Pharmaceuticals, holds 1.03M shares in Sonoma Pharmaceuticals (Ticker: SNOA). Most recently, Hojabr Alimi Bought 5,500 shares of Sonoma Pharmaceuticals on Dec 11, 2012 for an estimated value of $3.46K.
Hojabr Alimi's Trading History
| SNOASonoma Pharmaceuticals | Dec 11, 2012 | CEO, Director | Informative Buy | 3.46K | $1.14M | |
SNOA Insider Shares: 1.03M (6.28%) | ||||||
You May Also Like
Hojabr Alimi insider profile FAQ
What is the percentage of profitable transactions made by Hojabr Alimi?
The percentage of profitable transactions made by Hojabr Alimi is 25%.
What is the average return per transaction made by Hojabr Alimi?
The average return per transaction made by Hojabr Alimi is -26.70%.
What stocks does Hojabr Alimi hold?
Hojabr Alimi holds: SNOA stocks.
What was Hojabr Alimi’s latest transaction?
Hojabr Alimi’s latest transaction was an Informative Buy of $3.46K.
What was Hojabr Alimi's most profitable transaction?
Hojabr Alimi’s most profitable transaction was an Informative Sell of SNOA stock on March 11, 2010. The return on the trade was 17.10%.
What is Hojabr Alimi's role in Sonoma Pharmaceuticals?
Hojabr Alimi's role in Sonoma Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
